正海生物(300653)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300653 正海生物

已收盘 11-03 15:00:00

{"stockData":{"symbol":"300653","market":"SZ","secType":"STK","nameCN":"正海生物","latestPrice":13.84,"timestamp":1793689410000,"preClose":13.94,"halted":0,"volume":1635846,"delay":0,"changeRate":-0.0072,"floatShares":180000000,"shares":180000000,"eps":0.3525,"marketStatus":"已收盘","change":-0.1,"latestTime":"11-03 15:00:00","open":13.89,"high":14.2,"low":13.7,"amount":22755000,"amplitude":0.0359,"askPrice":13.84,"askSize":104,"bidPrice":13.83,"bidSize":53,"shortable":0,"etf":0,"ttmEps":0.3525,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793755800000},"marketStatusCode":5,"adr":0,"adjPreClose":13.94,"symbolType":"stock","openAndCloseTimeList":[[1793669400000,1793676600000],[1793682000000,1793689200000]],"highLimit":15.33,"lowLimit":12.55,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":180000000,"isCdr":false,"pbRate":2.83,"roa":"--","peRate":39.262411,"roe":"5.43%","epsLYR":0.46,"committee":0.504,"marketValue":2491000000,"turnoverRate":0.0091,"status":1,"floatMarketCap":2491000000},"requestUrl":"/m/hq/s/300653/tweets","defaultTab":"tweets","newsList":[{"id":"2679264652","title":"正海生物：公司口腔可吸收生物膜处于临床试验阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2679264652","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679264652?lang=zh_cn&edition=full","pubTime":"2026-10-30 15:07","pubTimestamp":1793344051,"startTime":"0","endTime":"0","summary":"证券之星消息，正海生物(300653)10月30日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司口腔膜目前在种植方面的销售量占口腔膜整体销售量的百分之多少？用于牙龈修复方面占比又是多少？新品口腔膜何时上市？在口腔方面连年承压的情况下有何规划？正海生物回复：尊敬的投资者您好，公司口腔可吸收生物膜处于临床试验阶段，如有相关事项达到披露标准，公司将严格按照规定及时履行信息披露义务。公司将继续推进膜骨材料组合推广、学术深耕、渠道优化等，同时强化全链条成本管控，更好地应对行业政策变化与市场竞争。感谢您的关注与支持！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000032547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300653","BK0046","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679264580","title":"正海生物：公司展会推广坚持双线并举","url":"https://stock-news.laohu8.com/highlight/detail?id=2679264580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679264580?lang=zh_cn&edition=full","pubTime":"2026-10-30 15:03","pubTimestamp":1793343798,"startTime":"0","endTime":"0","summary":"证券之星消息，正海生物10月30日在投资者关系平台上答复投资者关心的问题。公司展会推广坚持双线并举，一方面持续聚焦核心产品的院内准入、集采落地和常规临床推广，夯实基本盘；另一方面依托学术会议开展新术式、新场景临床探索，在成熟产品基础上挖掘合规新增量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000032427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0046","300653"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679264635","title":"正海生物：活性生物骨市场推广工作有序推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2679264635","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679264635?lang=zh_cn&edition=full","pubTime":"2026-10-30 15:03","pubTimestamp":1793343793,"startTime":"0","endTime":"0","summary":"证券之星消息，正海生物(300653)10月30日在投资者关系平台上答复投资者关心的问题。投资者提问：公司成新品推广需要周期可以理解，但是否应该为循序渐进缓慢增长？为何活性骨今年的销售额比去年毫无增长？甚至降低？请懂秘指点迷津。正海生物回复：尊敬的投资者您好，活性生物骨市场推广工作有序推进，整体运营态势平稳。产品所处赛道具备长期发展空间，公司持续深耕学术推广，稳步拓展终端覆盖，不断夯实产品的市场基础。感谢您的关注与支持！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000032425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0251","300653"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679025920","title":"正海生物：公司营收阶段性承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2679025920","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679025920?lang=zh_cn&edition=full","pubTime":"2026-10-30 09:09","pubTimestamp":1793322551,"startTime":"0","endTime":"0","summary":"证券之星消息，正海生物10月29日在投资者关系平台上答复投资者关心的问题。公司仍将不断优化营销结构，强化学术推广与终端临床服务，加快新品入院转化，持续夯实集采中标格局，同步推进管线注册。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000016670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300653"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679142259","title":"正海生物：海外业务方面公司坚持稳步推进、风险可控的原则","url":"https://stock-news.laohu8.com/highlight/detail?id=2679142259","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679142259?lang=zh_cn&edition=full","pubTime":"2026-10-30 09:06","pubTimestamp":1793322366,"startTime":"0","endTime":"0","summary":"证券之星消息，正海生物10月29日在投资者关系平台上答复投资者关心的问题。海外业务方面公司坚持稳步推进、风险可控的原则，依托成熟产品与合规体系逐步拓展国际市场。如有相关事项达到披露标准，公司将严格按照规定及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000016586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0046","300653"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679256510","title":"正海生物：存货增加系多款产品综合备货安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2679256510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679256510?lang=zh_cn&edition=full","pubTime":"2026-10-30 08:30","pubTimestamp":1793320226,"startTime":"0","endTime":"0","summary":"证券之星消息，正海生物(300653)10月29日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司存货增加系新品上市是指活性骨还是钙硅生物陶瓷？是否与骨形成蛋白集采有关？公司对于运医集采目前做了哪些应对准备？正海生物回复：尊敬的投资者您好，存货增加系多款产品综合备货安排，备货主要基于市场推广、生产及供应链规划统筹安排。公司持续跟踪相关集采政策动态，做好政策研判及应对准备。感谢您的关注与支持！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000015194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300653","BK0251","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679256341","title":"正海生物：钙硅生物陶瓷口腔骨修复材料已经正式进院销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2679256341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679256341?lang=zh_cn&edition=full","pubTime":"2026-10-30 08:30","pubTimestamp":1793320225,"startTime":"0","endTime":"0","summary":"证券之星消息，正海生物(300653)10月29日在投资者关系平台上答复投资者关心的问题。投资者提问：请问海奥3d三季度民营和公立销售情况？各大电商平台为啥看不到销售量？正海生物回复：尊敬的投资者您好，目前钙硅生物陶瓷口腔骨修复材料已经正式进院销售，公司正积极推进产品线上线下的渠道建设与市场推广工作。公司严格按照监管要求履行信息披露义务，部分经营信息涉及商业敏感信息暂未对外披露，敬请理解。感谢您的关注与支持！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000015190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300653","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679256346","title":"正海生物：三季度口腔膜粉终端降本控费压力较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2679256346","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679256346?lang=zh_cn&edition=full","pubTime":"2026-10-30 08:30","pubTimestamp":1793320224,"startTime":"0","endTime":"0","summary":"证券之星消息，正海生物(300653)10月29日在投资者关系平台上答复投资者关心的问题。投资者提问：请问三季度口腔膜粉营收情况？下滑比例？正海生物回复：尊敬的投资者您好，三季度口腔膜粉终端降本控费压力较大，产品竞争仍较为激烈，公司口腔修复膜产品的市场地位相对稳固。口腔领域作为公司发展的重要方向，未来公司仍将持续深耕该领域，加快新品上市与推广，进一步提升市场竞争能力。感谢您的关注与支持！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000015189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300653","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678498881","title":"正海生物（300653）2026年三季报简析：净利润同比下降27.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678498881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678498881?lang=zh_cn&edition=full","pubTime":"2026-10-28 20:37","pubTimestamp":1793191078,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期正海生物发布2026年三季报。根据财报显示，正海生物净利润同比下降27.8%。截至本报告期末，公司营业总收入2.31亿元，同比下降16.16%，归母净利润4843.42万元，同比下降27.8%。按单季度数据看，第三季度营业总收入7139.18万元，同比下降18.76%，第三季度归母净利润1512.81万元，同比下降27.67%。去年的净利率为22.63%，算上全部成本后，公司产品或服务的附加值高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800047852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300653"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678891784","title":"股市必读：正海生物三季报 - 第三季度单季净利润同比下降27.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678891784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678891784?lang=zh_cn&edition=full","pubTime":"2026-10-28 05:13","pubTimestamp":1793135624,"startTime":"0","endTime":"0","summary":"截至2026年10月27日收盘，正海生物报收于14.15元，下跌5.29%，换手率1.13%，成交量2.04万手，成交额2947.19万元。业绩披露要点：2026年前三季度主营收入2.31亿元、同比下降16.16%，归母净利润4843.42万元、同比下降27.8%；第三季度单季归母净利润1512.81万元、同比下降27.67%。股本股东变化股东户数变动截至2026年9月30日公司股东户数为1.62万户，较6月30日增加1871.0户，增幅为13.09%；户均持股数量由1.26万股减少至1.11万股，户均持股市值为17.75万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800006566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300653"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678752711","title":"正海生物(300653)9月30日股东户数1.62万户，较上期增加13.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678752711","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678752711?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:53","pubTimestamp":1793098397,"startTime":"0","endTime":"0","summary":"证券之星消息，近日正海生物披露，截至2026年9月30日公司股东户数为1.62万户，较6月30日增加1871.0户，增幅为13.09%。在医疗器械行业个股中，正海生物股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.08万户。从股价来看，2026年6月30日至2026年9月30日，正海生物区间涨幅为11.0%，在此期间股东户数增加1871.0户，增幅为13.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700035412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300653","BK0251","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678136118","title":"图解正海生物三季报：第三季度单季净利润同比下降27.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678136118","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678136118?lang=zh_cn&edition=full","pubTime":"2026-10-27 01:36","pubTimestamp":1793036182,"startTime":"0","endTime":"0","summary":"证券之星消息，正海生物2026年三季报显示，前三季度公司主营收入2.31亿元，同比下降16.16%；归母净利润4843.42万元，同比下降27.8%；扣非净利润4000.12万元，同比下降32.41%；其中2026年第三季度，公司单季度主营收入7139.18万元，同比下降18.76%；单季度归母净利润1512.81万元，同比下降27.67%；单季度扣非净利润1284.41万元，同比下降33.78%；负债率9.03%，投资收益498.47万元，财务费用-14.31万元，毛利率82.34%。财报数据概要请见下图:本文数据来源于正海生物2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700003024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300653"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675324490","title":"股市必读：正海生物（300653）10月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2675324490","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675324490?lang=zh_cn&edition=full","pubTime":"2026-10-15 03:24","pubTimestamp":1792005886,"startTime":"0","endTime":"0","summary":"截至2026年10月14日收盘，正海生物报收于15.23元，下跌2.5%，换手率0.78%，成交量1.41万手，成交额2158.92万元。交易信息汇总资金流向10月14日主力资金净流出79.72万元，占总成交额3.69%；游资资金净流出127.58万元，占总成交额5.91%；散户资金净流入207.3万元，占总成交额9.6%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500003584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300653","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675392216","title":"正海生物：公司宫腔修复膜目前仍处于注册审评阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2675392216","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675392216?lang=zh_cn&edition=full","pubTime":"2026-10-14 11:33","pubTimestamp":1791948799,"startTime":"0","endTime":"0","summary":"证券之星消息，正海生物(300653)10月14日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，公司新产品宫腔修复膜去年10月已经完成临床实验，请问医疗器械注册审批进展如何，预计何时可以上市销售？谢谢！正海生物回复：尊敬的投资者您好，公司宫腔修复膜目前仍处于注册审评阶段。公司将根据项目进展及信息披露规则履行信息披露义务，感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400016250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0046","300653"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673012750","title":"股市必读：正海生物（300653）9月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2673012750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673012750?lang=zh_cn&edition=full","pubTime":"2026-10-08 02:33","pubTimestamp":1791397989,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，正海生物报收于15.94元，上涨1.27%，换手率1.23%，成交量2.21万手，成交额3527.64万元。董秘最新回复投资者： 请问公司对曾经作为再生医学领导者，现在市值却纷纷被奥精医疗 冠昊生物 迈普医学翻超！当日关注点交易信息汇总：9月30日主力资金净流入314.2万元，占总成交额8.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300653","BK0046","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671275010","title":"正海生物：持续深耕再生医学主业","url":"https://stock-news.laohu8.com/highlight/detail?id=2671275010","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671275010?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:03","pubTimestamp":1790751793,"startTime":"0","endTime":"0","summary":"证券之星消息，正海生物09月30日在投资者关系平台上答复投资者关心的问题。公司将持续深耕再生医学主业，加大研发与产品创新，优化产品矩阵、提升服务质量，聚焦核心产品临床价值挖掘、新产品管线推进及市场渠道深耕，持续优化经营质量，强化市场竞争力与品牌影响力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000018660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0251","300653"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667654843","title":"公司问答丨正海生物：钙硅生物陶瓷口腔骨修复材料已经正式进院销售 产品现已在全国25个省份实现挂网","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654843","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667654843?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:19","pubTimestamp":1789377552,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300653","BK0251","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666518887","title":"股市必读：正海生物新发布《关于召开2026年第二次临时股东会的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666518887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666518887?lang=zh_cn&edition=full","pubTime":"2026-09-11 02:34","pubTimestamp":1789065251,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，正海生物报收于15.15元，下跌2.95%，换手率1.02%，成交量1.83万手，成交额2790.9万元。当日关注点交易信息汇总：9月10日主力资金净流出247.52万元，占总成交额8.87%。公司公告汇总：正海生物将于9月15日召开2026年第二次临时股东大会，审议修订《董事会议事规则》议案，股权登记日为9月8日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300653","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664603806","title":"股市必读：正海生物（300653）9月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2664603806","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664603806?lang=zh_cn&edition=full","pubTime":"2026-09-04 02:05","pubTimestamp":1788458716,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘，正海生物报收于15.08元，下跌1.11%，换手率1.01%，成交量1.81万手，成交额2730.03万元。董秘最新回复投资者： 公司在研发周期转产周期销售推广周期方面是否可以提效提速？当日关注点交易信息汇总：9月3日主力资金净流入163.97万元，占总成交额6.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400002437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300653","BK0251","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662670080","title":"正海生物：公司会结合实际经营情况及长期发展战略，综合考量并购事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=2662670080","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662670080?lang=zh_cn&edition=full","pubTime":"2026-08-27 20:48","pubTimestamp":1787834889,"startTime":"0","endTime":"0","summary":"证券之星消息，正海生物(300653)08月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司有无回购或并购计划？理财产品利率下降的时点是否有计划充分合理的利用手中现金？改善公司经营现状？正海生物回复：尊敬的投资者您好，公司会结合实际经营情况及长期发展战略，综合考量并购事宜。若有相关回购或并购进展，公司将依法履行相关审议程序并及时进行信息披露。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700051139.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0046","300653"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793699575400,"stockEarnings":[{"period":"1week","weight":-0.0669},{"period":"1month","weight":-0.1255},{"period":"3month","weight":-0.053},{"period":"6month","weight":-0.2214},{"period":"1year","weight":-0.3022},{"period":"ytd","weight":-0.29}],"compareEarnings":[{"period":"1week","weight":-0.0161},{"period":"1month","weight":-0.0531},{"period":"3month","weight":-0.0482},{"period":"6month","weight":-0.1255},{"period":"1year","weight":-0.0801},{"period":"ytd","weight":-0.0834}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"烟台正海生物科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"16165人(较上一季度增加13.09%)","perCapita":"11135股","listingDate":"2017-05-16","address":"山东省烟台市福山区经济技术开发区南京大街7号","registeredCapital":"18000万元","survey":"　　烟台正海生物科技股份有限公司的主营业务是生物再生材料的研发、生产与销售。公司的主要产品是口腔修复膜、可吸收硬脑（脊）膜补片、活性生物骨、钙硅生物陶瓷口腔骨修复材料、皮肤修复膜。公司是国家首批专精特新“小巨人”企业、国家知识产权示范企业、国家智能制造优秀场景企业、高新技术企业。","listedPrice":11.72},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"正海生物(300653)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供正海生物(300653)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"正海生物,300653,正海生物股票,正海生物股票老虎,正海生物股票老虎国际,正海生物行情,正海生物股票行情,正海生物股价,正海生物股市,正海生物股票价格,正海生物股票交易,正海生物股票购买,正海生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"正海生物(300653)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供正海生物(300653)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}